Melatonin is one of the most widely used sleep supplements globally, yet experts say its misuse—particularly incorrect dosing and timing—may undermine its effectiveness. According to sleep specialist Gonzalo Pin, a researcher at the University of Barcelona, the hormone’s benefits hinge far more on when it’s taken than how much. His findings, backed by recent clinical studies, challenge common practices and offer clear guidance for those struggling with sleep disorders.
Pin’s insights come as melatonin sales in the U.S. alone reached $1.2 billion in 2023, driven by its perceived safety and accessibility. Yet, research published in the Journal of Clinical Sleep Medicine last year found that nearly 60% of users take melatonin incorrectly, often in doses far exceeding recommended levels. Pin argues that this approach not only fails to address insomnia but may also disrupt natural circadian rhythms over time.
The confusion stems from melatonin’s dual role: as a natural hormone regulating sleep-wake cycles and as a supplement marketed for jet lag, shift work, and age-related sleep disturbances. While the UK’s National Health Service and the U.S. Food and Drug Administration (FDA) classify it as a dietary supplement, its long-term effects remain understudied. Pin’s work highlights a critical gap: most users prioritize dosage over timing, despite evidence showing that melatonin’s half-life—how long it remains active in the body—varies significantly by individual metabolism.
Video: How melatonin works in the body (Source: University of Barcelona Sleep Research Lab)
Why Timing Over Dose: The Science Behind Melatonin’s Effectiveness
Melatonin’s primary function is to signal darkness to the brain, triggering the onset of sleep. Produced naturally by the pineal gland, its secretion peaks between 10 p.m. and 2 a.m., aligning with the body’s circadian rhythm. When taken as a supplement, its efficacy depends on mimicking this natural release.
Pin’s research, published in Sleep Medicine Reviews, demonstrates that taking melatonin 30–60 minutes before the desired bedtime maximizes its impact. This window allows the hormone to synchronize with the body’s internal clock, whereas taking it earlier (e.g., mid-afternoon) or later (e.g., right before bed) can lead to grogginess or disrupted sleep architecture. “The dose is less important than the timing,” Pin states. “A 0.5-milligram dose taken correctly can be more effective than 5 milligrams taken at the wrong time.”
Clinical trials cited by the Sleep Foundation support this: participants who took melatonin 90 minutes before bedtime reported improved sleep latency (time to fall asleep) by an average of 12 minutes, compared to those who took it at inconsistent intervals. However, doses exceeding 3 milligrams—common in over-the-counter products—have shown no additional benefit and may increase side effects like daytime drowsiness.
Common Mistakes: How Most Users Get Melatonin Wrong
Pin identifies three prevalent errors in melatonin use, each with distinct consequences:
- Taking it too early: Melatonin’s half-life averages 4–6 hours, meaning it can linger in the system. Consuming it in the late afternoon (e.g., 3 p.m.) may cause drowsiness before bedtime, disrupting natural sleep onset.
- Overdosing: While melatonin is generally safe, doses above 5 milligrams have been linked to increased risk of depression-like symptoms in some studies, likely due to hormonal imbalances.
- Inconsistent timing: Taking melatonin sporadically (e.g., only on weekends) can confuse the body’s internal clock, worsening chronic insomnia over time.
Pin’s advice aligns with guidelines from the American Academy of Sleep Medicine (AASM), which recommends melatonin only for short-term use (up to 3 months) and at the lowest effective dose. For persistent sleep issues, he advises consulting a sleep specialist to rule out underlying conditions like sleep apnea or circadian rhythm disorders.
Who Should Avoid Melatonin—and What Are the Alternatives?
While melatonin is safe for most healthy adults, certain groups should approach it with caution:
- Children and adolescents: The FDA advises against melatonin use in children under 18 due to limited safety data. Pediatric sleep disorders should be evaluated by a doctor.
- Pregnant or breastfeeding women: Melatonin’s effects during pregnancy remain unstudied, and experts recommend avoiding it unless prescribed.
- Those on medications: Melatonin may interact with blood thinners, immunosuppressants, and diabetes drugs. Pin recommends checking with a pharmacist.
For those who cannot or should not use melatonin, Pin suggests non-pharmacological approaches backed by the Sleep Foundation:
- Consistent sleep schedule (within 1 hour daily).
- Light exposure management (bright light in the morning, dim light at night).
- Cognitive behavioral therapy for insomnia (CBT-I), the gold standard for chronic sleep issues.
- Supplements like magnesium glycinate or chamomile tea, which have milder effects on sleep architecture.
What Happens Next: Research and Regulatory Updates
The European Medicines Agency (EMA) is currently reviewing melatonin’s classification, with a public consultation open until October 2024 to assess its safety and efficacy. Meanwhile, the FDA is investigating reports of contamination in some melatonin products, including traces of heavy metals and undeclared ingredients.

Pin’s team at the University of Barcelona is leading a multi-year study on melatonin’s long-term effects, with preliminary findings expected in 2025. Until then, he advises users to:
- Start with the lowest dose (0.5–1 milligram).
- Take it 30–60 minutes before bedtime.
- Avoid long-term use without medical supervision.
- Choose third-party tested products (look for ConsumerLab or USP Verified seals).
Key Considerations for Melatonin Use
- Timing is critical: 30–60 minutes before bedtime optimizes effectiveness.
- Dose matters less: 0.5–3 milligrams is typically sufficient; higher doses offer no proven benefit.
- Consistency is key: Take it at the same time daily to regulate circadian rhythms.
- Not for everyone: Children, pregnant women, and those on medications should consult a doctor.
- Quality matters: Choose products tested for purity and potency.
For readers seeking personalized advice, Pin recommends using the Sleep Foundation’s sleep calculator or consulting a board-certified sleep specialist. The next major update on melatonin regulation is expected from the EMA in late 2024, with potential label changes based on ongoing research.
Have you tried melatonin? Share your experiences in the comments below—or tag us on Twitter to join the conversation.